Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5079 | 1609 | 31.3 | 79% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LIVER KIDNEY DIS TRANSPLANTAT | Address | 9 | 52% | 1% | 12 |
2 | HCV VIREMIA | Author keyword | 7 | 57% | 0% | 8 |
3 | NOSOCOMIAL TRANSMISSION | Author keyword | 5 | 17% | 2% | 25 |
4 | POST NEPHROL PROGRAM | Address | 3 | 50% | 0% | 4 |
5 | AMINOTRANSFERASE ACTIVITY | Author keyword | 3 | 60% | 0% | 3 |
6 | CHRONIC HEMODIALYSIS PATIENTS | Author keyword | 2 | 44% | 0% | 4 |
7 | ABDOMINAL TRANSPLANTAT PROGRAM | Address | 2 | 67% | 0% | 2 |
8 | EPIDEMIOLOGIC FACTOR | Author keyword | 2 | 67% | 0% | 2 |
9 | HEPATOSIDEROSIS | Author keyword | 2 | 67% | 0% | 2 |
10 | KIDNEY TRANSPLANT PATIENT | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 3RD GENERATION ASSAYS | 31 | 92% | 1% | 12 |
2 | ANTI HCV | 27 | 29% | 5% | 77 |
3 | PEGYLATED INTERFERON ALPHA 2B MONOTHERAPY | 23 | 100% | 1% | 10 |
4 | LOW DOSE RIBAVIRIN | 19 | 80% | 1% | 12 |
5 | SGOT ACTIVITY | 17 | 79% | 1% | 11 |
6 | DIALYSIS UNITS | 15 | 73% | 1% | 11 |
7 | POSITIVE HEMODIALYSIS PATIENTS | 14 | 100% | 0% | 7 |
8 | CADAVER ORGAN DONORS | 13 | 80% | 0% | 8 |
9 | KIDNEY TRANSPLANT CANDIDATES | 12 | 86% | 0% | 6 |
10 | ANTIBODY STATUS | 12 | 59% | 1% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Hepatitis C and its impact on renal transplantation | 2015 | 2 | 94 | 76% |
Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality? | 2012 | 14 | 31 | 74% |
The impact of Hepatitis C virus infection on kidney transplantation outcomes: A systematic review of 18 observational studies | 2011 | 20 | 27 | 89% |
Hepatitis C Infection and Chronic Renal Diseases | 2009 | 77 | 117 | 46% |
Management of hepatitis C in patients with chronic kidney disease | 2015 | 1 | 166 | 73% |
Hepatitis C virus and kidney disease | 2008 | 34 | 122 | 83% |
Hepatitis C virus infection in dialysis and renal transplantation | 1997 | 259 | 198 | 54% |
Hepatitis C virus infection in hemodialysis patients | 2013 | 9 | 42 | 86% |
Hepatitis C and renal transplantation | 2012 | 7 | 32 | 88% |
Hepatitis C in hemodialysis patients: Current global magnitude, natural history, diagnostic difficulties, and preventive measures | 2008 | 30 | 131 | 79% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LIVER KIDNEY DIS TRANSPLANTAT | 9 | 52% | 0.7% | 12 |
2 | POST NEPHROL PROGRAM | 3 | 50% | 0.2% | 4 |
3 | ABDOMINAL TRANSPLANTAT PROGRAM | 2 | 67% | 0.1% | 2 |
4 | UNITE HEPATOL | 2 | 11% | 0.8% | 13 |
5 | BC TRANSPLANT SOC | 1 | 100% | 0.1% | 2 |
6 | CARDIOVASC MED NEPHROL ENDOCRINOL | 1 | 50% | 0.1% | 2 |
7 | SERV NEPHROL HEMODIALYSE TRANSPLANTAT ORGANES | 1 | 100% | 0.1% | 2 |
8 | BC HEPATITIS PROGRAM | 1 | 40% | 0.1% | 2 |
9 | HEALTHCARE OUTCOMES BRANCH | 1 | 40% | 0.1% | 2 |
10 | HEPATOL BRANCH | 1 | 40% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000141393 | RIBA//ANTI HCV//NON A NON B HEPATITIS |
2 | 0.0000111268 | HEPATITIS B IMMUNOGLOBULIN//HBIG//HEPATITIS B RECURRENCE |
3 | 0.0000092839 | ACUTE HEPATITIS C//INTRAFAMILIAL TRANSMISSION//MOTHER TO INFANT TRANSMISSION |
4 | 0.0000080426 | HCV GENOTYPES//INTERFERON SENSITIVITY DETERMINING REGION//HYPERVARIABLE REGION 1 |
5 | 0.0000070331 | HEPATITIS C RECURRENCE//RECURRENT HEPATITIS C//HCV RECURRENCE |
6 | 0.0000070081 | SAHLGRENS HOSP CLIN PHYSIOL//CENT HOSP MED 4 UNIONINKATU 38//LIVING RELATED KIDNEY TRANSPLANT |
7 | 0.0000060639 | CHRONIC HEPATITIS C//INTERFERON THERAPY//HCV RNA |
8 | 0.0000058760 | HIGH RISK DONOR//DONOR DERIVED INFECTION//DONOR TO HOST TRANSMISSION |
9 | 0.0000057350 | CRYOGLOBULINEMIA//MIXED CRYOGLOBULINEMIA//CRYOGLOBULINAEMIA |
10 | 0.0000056060 | HBV REACTIVATION//HEPATITIS B VIRUS REACTIVATION//HEPATITIS B REACTIVATION |